Forecast: Basic Pharmaceutical Products Production Value in the Netherlands

The production value of basic pharmaceutical products in the Netherlands has experienced significant growth from 2013 to 2023. Starting at 130.2 million Euros in 2013, it rose to 659.1 million Euros by 2023. The year-on-year growth rates have varied over the years, with notable increases in recent years such as 59.47% in 2020 and 29.81% in 2021. The compound annual growth rate (CAGR) over the last five years stands at 30.61%, indicating strong momentum in production value growth.

Looking to the future, forecasted data suggests a continued positive trend with the production value expected to reach 1200.0 million Euros by 2028. The forecasted five-year CAGR is 9.28%, signifying a robust but slightly moderated growth compared to previous years.

Future trends to watch for:

● Continued innovation and advancements in pharmaceutical technologies.

● Impact of regulatory changes and healthcare policies in the EU.

● Fluctuations in global demand and supply chain dynamics.

● Increased focus on sustainability and green manufacturing practices.